Category: Clinical Trial
Global Clinical Trial
-
Clinical Data Analytics
... at a CAGR of 30.5% over the analysis period 2024-2030. Quality Care, one of the segments analyzed in the report, is expected to record a 29.7% CAGR and reach US$58.8 Billion by the end of ... Read More
-
Regulatory Affairs Outsourcing
... at a CAGR of 8.5% over the analysis period 2024-2030. Regulatory Submissions, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$1.7 Billion by the end of ... Read More
-
Electronic Data Capture
... at a CAGR of 13.6% over the analysis period 2024-2030. Services, one of the segments analyzed in the report, is expected to record a 13.0% CAGR and reach US$1.4 Billion by the end of the ... Read More
-
Cell And Gene Therapy CDMO Market Size, Share & Trends Analysis Report By Phase (Pre-clinical, Clinical), By Product Type (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), By Indication (Oncology, Infectious Diseases), By Region, And Segment- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
... the forecast period from 2024 to 2033. Key Takeaways: North America accounts for the largest share of 40.18% in 2023. Asia Pacific, on the other hand, is anticipated to register a lucrative CAGR of 29.1% ... Read More
-
In Vivo CRO Market Size, Share & Trends Analysis Report By Model Type (Rodent Based, Non-rodent Based), By Modality (Small Molecule, Large Molecule), By Indication, By GLP Type (Non GLP, GLP Toxicology), By Region, )- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
... a CAGR of 8.34% from 2024 to 2033. In Vivo CRO Market Key Takeaways In 2023, the rodent based segment dominated the market with a revenue share of 81.76%. The non-rodent based segment is expected ... Read More
-
Electronic Clinical Outcome Assessment (eCOA) Solutions Market by Modality (Wearable, Mobile, BYOD), Type (PRO, CLINRO, OBSRO, PERFO), Application (Clinical Trial (Onco, Rare, Mental Health), RWE, Registery), End User (Govt, Med Device, Pharma) - Global Forecast to 2030
... towards digital data collection and analysis, an escalating need for economic data collection solutions, and the increasing integration of connected devices in healthcare institutions are the factors that will drive the growth of this market. ... Read More
-
Graft Versus Host Disease (GVHD) - Global Clinical Trials Review, 2025
... Disease (GVHD) Clinical trials scenario. This report provides top line data relating to the clinical trials on Graft Versus Host Disease (GVHD). Report includes an overview of trial numbers and their average enrollment in top ... Read More
-
Neuropathic Pain (Neuralgia) - Global Clinical Trials Review, 2025
... report provides top line data relating to the clinical trials on Neuropathic Pain (Neuralgia). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ... Read More
-
Seasonal Influenza - Global Clinical Trials Review, 2025
... line data relating to the clinical trials on Seasonal Influenza. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ... Read More
-
Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2025
... trials scenario. This report provides top line data relating to the clinical trials on Atopic Dermatitis (Atopic Eczema). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the ... Read More
-
Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Global Clinical Trials Review, 2025
... of Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) Clinical trials scenario. This report provides top line data relating to the clinical trials on Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome). Report includes an overview of ... Read More
-
Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) - Global Clinical Trials Review, 2025
... Review, 2025" - provides an overview of Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Clinical trials scenario. This report provides top line data relating to the clinical trials on Multiple System Atrophy ... Read More
-
Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2025
... report provides top line data relating to the clinical trials on Duchenne Muscular Dystrophy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ... Read More
-
Chemotherapy-Induced Diarrhea (CID) - Global Clinical Trials Review, 2025
... report provides top line data relating to the clinical trials on Chemotherapy-Induced Diarrhea (CID). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ... Read More
-
Thrombocytopenia - Global Clinical Trials Review, 2025
... to the clinical trials on Thrombocytopenia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country ... Read More
-
Aplastic Anemia - Global Clinical Trials Review, 2025
... line data relating to the clinical trials on Aplastic Anemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ... Read More
-
Global MRNA Vaccines and Therapeutics Market - 2025-2033
... 2033, growing at a CAGR of 8.5% during the forecast period 2025-2033. The mRNA vaccines and therapeutics market is experiencing rapid growth, driven by the proven success of mRNA-based COVID-19 vaccines and the expanding potential ... Read More
-
2025 Global: In-Silico Clinical Trials Market - Innovative Markets Forecast (2031) report
... industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market ... Read More
-
Global Locally Advanced Pancreatic Cancer Market- 2022-2033
... Locally advanced pancreatic cancer refers to a stage of pancreatic cancer where the tumor is confined to the pancreas and the surrounding areas but has not spread to distant organs like the liver, lungs, or ... Read More
-
Contract Research Organization Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
... across pharmaceutical, biotechnology, and medical device sectors, alongside the rising complexity of clinical trials and personalized medicine demands. The widespread outsourcing of research activities to contract research organizations (CROs) allows companies to focus on core ... Read More
-
Cell And Gene Therapy Clinical Trial Services Global Market Report 2025
... on cell and gene therapy clinical trial services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. ... Read More
-
e-Clinical Trial Technologies
... at a CAGR of 13.1% over the analysis period 2024-2030. Clinical Trial Management Systems (CTMS), one of the segments analyzed in the report, is expected to record a 13.8% CAGR and reach US$9.9 Billion by ... Read More
-
Peripheral Arterial Disease (PAD) Therapeutics
... Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Peripheral Stents, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$1.8 Billion ... Read More
-
Biosimulation Technology
... CAGR of 15.6% over the analysis period 2024-2030. Software, one of the segments analyzed in the report, is expected to record a 14.8% CAGR and reach US$5.7 Billion by the end of the analysis period. ... Read More
-
Acute Myeloid Leukemia (AML) Therapeutics
... Billion by 2030, growing at a CAGR of 13.3% over the analysis period 2024-2030. Cytarabine, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$592.7 Million by ... Read More
Research Assistance
